Abstract
Surgical resection continues to offer the only hope for cure of colorectal cancer metastatic to the liver. Tumor involvement of the vena cava is often viewed as a contraindication to surgical resection. Whereas proven technically feasible, the survival advantages of en bloc liver and vena cava resection remain unclear. We reviewed all patients at a tertiary care center who had resection of colorectal liver metastases, including those with vena cava resections. Eleven patients had en bloc liver and vena cava resection between 1988 and 2002; during the same time period, 97 patients underwent isolated liver resection. There were no perioperative deaths in the 11 patients. All resections had negative histological margins. Mean follow-up was 33 months from the date of surgery. Median disease-free survival of the group having caval resections was 9 months, whereas median survival was 34 months. When compared to the cohort of isolated hepatic resections, the group undergoing caval resections experienced a significantly reduced diseasefree survival of 18.6 vs. 9.1 months, respectively (P = 0.03); however, there was no difference in overall survival between the two groups at 55.2 vs. 34.3 months, respectively (P = 0.20). Colorectal liver metastases involving the vena cava should be considered for surgical resection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Leading sites of new cancer cases and death in the United States, 2005. (American Cancer Society [website], Cancer Facts and Figures 2005. Available at: http://www.cancer.org. Accessed July 2005.)
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resec tion for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230(3):309–318.
Harmon KE, Ryan JA Jr, Biehl TR, Lee FT. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 1999;177(5):402–404.
Bradley AL, Chapman WC, Wright JK, et al. Surgical experience with hepatic colorectal metastasis. Am Surg 1999; 65(6):560–566.
Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in longterm survival after liver resection for hepatic colorectal metastases. Ann Surg 2002;235(6):759–766.
Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg 1998; 22(3):268–276.
Nakamura S, Suzuki S, Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years’ experience. J Hepatobiliary Pancreat Surg 1999;6(1):16–22.
Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22(1):23–30.
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350(23):2335–2342.
Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999; 230(1):1–8.
Hemming AW, Langham MR, Reed AI, van der Werf WJ, Howard RJ. Resection of the inferior vena cava for hepatic malignancy. Am Surg 2001;67(11):1081–1087.
Hemming AW, Reed AI, Langham MR Jr, Fujita S, Howard RJ. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg 2004;239(5):712–719.
Lodge JP, Ammori BJ, Prasad KR, Bellamy MC. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg 2000;231(4):471–479.
Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Am J Surg 1999;177(4):294–298.
Primrose JN. Treatment of colorectal metastases: Surgery, cryotherapy, or radiofrequency ablation. Gut 2002;50(1):1–5.
Aoki T, Sugawara Y, Imamura H, et al. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer. J Am Coll Surg 2004;198(3):366–372.
Abdalla EK, VautheyJN, Ellis LM, et al. Recurrence and outcomes after hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239(6):818–825.
Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221(1):159–166.
Scudamore CH, Lee SI, Patterson EJ, et al. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999;177(5):411–417.
Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003;14(10):1267–1274.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, S.T., Blitz, M., Kneteman, N. et al. combined hepatic and inferior vena cava resection for colorectal metastases. J Gastrointest Surg 10, 220–226 (2006). https://doi.org/10.1016/j.gassur.2005.09.012
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.09.012